Reference health

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States

https://doi.org/10.1101/2021.07.08.21259776
CiteStamped reference-health badge
25/25 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 25 checked references that resolve
resolves10.1056/NEJMoa2035389
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
resolves10.1056/NEJMoa2034577
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
resolves10.15585/mmwr.mm6915e3
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
resolves10.1093/cid/ciab462
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019–2020: A Test-Negative Study
resolves10.1093/cid/ciaa407
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018
resolves10.1093/infdis/jiy723
Prevention of Influenza Hospitalization Among Adults in the United States, 2015–2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)
resolves10.1016/j.vaccine.2013.04.026
The case test-negative design for studies of the effectiveness of influenza vaccine
resolves10.1101/2021.01.21.21250258
Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines
resolves10.15585/mmwr.mm7018e1
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
resolves10.7326/M20-0504
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
resolves10.1093/infdis/jiab273
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates
resolves10.1093/cid/ciaa1453
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND)
resolves10.17504/protocols.io.bp2l6n26rgqe/v3
nCoV-2019 sequencing protocol v3 (LoCost) v3
resolves10.1038/s41564-020-0770-5
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
resolves10.1056/NEJMoa1700153
Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season
resolves10.1371/journal.pone.0071079
Does Raising Type 1 Error Rate Improve Power to Detect Interactions in Linear Regression Models? A Simulation Study
resolves10.15585/mmwr.mm7013e3
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
resolves10.15585/mmwr.mm7020e2
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021
resolves10.1097/TP.0000000000003863
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
resolves10.7326/M21-1451
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series
resolves10.3201/eid2608.191493
Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States
resolves10.1056/NEJMoa2101765
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
resolves10.3201/eid2705.204523
Racial and Ethnic Disparities in Incidence of SARS-CoV-2 Infection, 22 US States and DC, January 1–October 1, 2020
resolves10.1016/S0140-6736(20)30566-3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
resolves10.1001/jamanetworkopen.2021.8828
Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic
The 7 references without a DOI — listed, not checked
no DOI — not checkedCenters for Disease Control and Prevention. COVID data tracker. Available at: https://covid.cdc.gov/covid-data-tracker/#datatracker-home. Accessed on: 26 May 2021.
no DOI — not checkedU.S. Food & Drug Administration. COVID-19 vaccines. Available at: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines. Accessed on: 26 May 2021.
no DOI — not checkedWorld Health Organization. Evaluation of COVID-19 vaccine effectiveness: Interim guidance. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1. Accessed on: 25 June 2021.
no DOI — not checkedU.S. Food & Drug Administration. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel. Available at: https://www.fda.gov/media/134922/download. Accessed on: 26 May 2021.
no DOI — not checkedCenters for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. Available at: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#footnote-01. Accessed on: 1 June 2021.
no DOI — not checkedHealthData.gov. COVID-19 reported patient impact and hospital capacity by state. Available at: https://beta.healthdata.gov/dataset/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/6xf2-c3ie. Accessed on: 27 May 2021.
no DOI — not checkedUnited States Census Bureau. Annual estimates of the resident population. Available at: https://data.census.gov/cedsci/table?q=state%20popuation&g=0100000US.04000.001&tid=PEPPOP2019.PEPANNRES&hidePreview=true. Accessed on: 27 May 2021.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1101/2021.07.08.21259776"><img src="https://citestamp.com/citestamped/10.1101/2021.07.08.21259776/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1101/2021.07.08.21259776/badge.svg)](https://citestamp.com/citestamped/10.1101/2021.07.08.21259776)